In fact, through the analysis of large sets of primary prostate cancer tumor samples it was provided evidence that RB expression was maintained in in situ prostate carcinomas, but it is lost in the majority of metastatic prostate cancers [293]. This evidence concerns the gene RB1 and prostate cancer.